Prevalence of monoclonal gammopathy among patients with psoriatic arthritis

Journal of Rheumatology

Volumn 39, Issue 3, 2012, Pages 564-567

  Eder, Lihi ^a,b,c   Thavaneswaran, Arane ^a,b,c   Pereira, Daniel ^a,b,c   Sussman, Gordon ^a,b,c   Gladman, Dafna D ^a,c,d,e  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Gammaglobulin; Monoclonal gammopathy; Prevalence; Psoriatic arthritis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; HEMOGLOBIN; IMMUNOGLOBULIN;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD ANALYSIS; CANADA; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PREVALENCE; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; PSORIATIC ARTHRITIS;

ADULT; AGE FACTORS; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PARAPROTEINEMIAS; PREVALENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84857872666     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.111054     Document Type: Article

References (15)

1. Langley RG, Krueger GG, Griffiths CE. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005;64 Suppl 2:ii18-23; discussion ii4-5.
2. Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis (PSA) - An analysis of 220 patients. Q J Med 1987;62:127-41. (Pubitemid 17042878)
3. Gaspari AA. Innate and adaptive immunity and the pathophysiology of psoriasis. J Am Acad Dermatol 2006;54 Suppl 2:S67-80. (Pubitemid 43243477)
4. Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: A prospective study. Blood 2009;113:5412-7.
5. Hillengass J, Moehler T, Hundemer M. Monoclonal gammopathy and smoldering multiple myeloma: Diagnosis, staging, prognosis, management. Recent Results Cancer Res 2011;183:113-31.
6. Crawford J, Eye MK, Cohen HJ. Evaluation of monoclonal gammopathies in the "well" elderly. Am J Med 1987;82:39-45. (Pubitemid 17087031)
7. Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 2006;354:1362-9.
8. Brown LM, Gridley G, Check D, Landgren O. Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood 2008;111:3388-94.
9. Peltonen L, Nikoskelainen E, Katka K, Tyrkko J. Monoclonal IgG immunoglobulinemia with subsequent myeloma in psoriatic arthritis. Dermatologica 1984;169:207-10. (Pubitemid 14032963)
10. Scherf I, Nahir M, Brick R, Joffe G, Tatarsky J. Monoclonal IgG immunoglobulinemia in psoriatic arthritis. Dermatologica 1980;160:348-50. (Pubitemid 10128847)
11. Prignano F, Pescitelli L, Ricceri F, Ermini A, Lotti T. Development of MGUS in psoriatic patients: A possible undiagnosed event during anti-TNF-α-treatment. J Eur Acad Dermatol Venereol 2011 Aug 11. [E-pub ahead of print]
12. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: Development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73. (Pubitemid 44205029)
13. Anderson LA, Gadalla S, Morton LM, Landgren O, Pfeiffer R, Warren JL, et al. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer 2009;125:398-405.
14. Landgren O, Linet MS, McMaster ML, Gridley G, Hemminki K, Goldin LR. Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: A population-based case-control study. Int J Cancer 2006;118:3095-8.
15. Ali YM, Urowitz MB, Ibanez D, Gladman DD. Monoclonal gammopathy in systemic lupus erythematosus. Lupus 2007;16:426-9. (Pubitemid 47122216)